These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6700103)

  • 41. Rubella control in Italy.
    Ciofi degli Atti M; Filia A; Revello MG; Buffolano W; Salmaso S
    Euro Surveill; 2004 Apr; 9(4):19-21. PubMed ID: 15192262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States.
    Reef SE; Redd SB; Abernathy E; Kutty P; Icenogle JP
    J Infect Dis; 2011 Sep; 204 Suppl 2():S593-7. PubMed ID: 21954252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
    Chua YX; Ang LW; Low C; James L; Cutter JL; Goh KT
    Vaccine; 2015 Jun; 33(27):3150-7. PubMed ID: 25887085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rubella and congenital rubella--United States, 1983.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 May; 33(18):237-42, 247. PubMed ID: 6425622
    [No Abstract]   [Full Text] [Related]  

  • 46. Elimination of rubella and congenital rubella syndrome in the Americas.
    Castillo-Solórzano C; Marsigli C; Bravo-Alcántara P; Flannery B; Ruiz Matus C; Tambini G; Gross-Galiano S; Andrus JK
    J Infect Dis; 2011 Sep; 204 Suppl 2():S571-8. PubMed ID: 21954249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ; Orenstein WA; Hinman AR
    Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rubella immunization of hospital personnel: a debate.
    Evans ME; Schaffner W
    Infect Control; 1981; 2(5):387-90. PubMed ID: 6913547
    [No Abstract]   [Full Text] [Related]  

  • 49. Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study.
    Su Q; Feng Z; Hao L; Ma C; Hagan JE; Grant GB; Wen N; Fan C; Yang H; Rodewald LE; Wang H; Glasser JW
    Lancet Infect Dis; 2021 Jul; 21(7):1004-1013. PubMed ID: 33515508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM; Grenfell BT
    J Hyg (Lond); 1986 Apr; 96(2):305-33. PubMed ID: 3701044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leads from the MMWR. Rubella and congenital rubella--United States, 1983.
    JAMA; 1984 Jun; 251(21):2774-5, 2779. PubMed ID: 6716604
    [No Abstract]   [Full Text] [Related]  

  • 52. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada.
    Hahné S; Macey J; van Binnendijk R; Kohl R; Dolman S; van der Veen Y; Tipples G; Ruijs H; Mazzulli T; Timen A; van Loon A; de Melker H
    Pediatr Infect Dis J; 2009 Sep; 28(9):795-800. PubMed ID: 19710586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Top end rural and remote Indigenous women: an Australian population group vulnerable to rubella.
    Hunt JM; Lumley J
    Commun Dis Intell Q Rep; 2004; 28(4):499-503. PubMed ID: 15745399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nationwide rubella epidemic--Japan, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(23):457-62. PubMed ID: 23760185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Rubella epidemiology in Italy in years 1998-2004].
    Giambi C; Rota MC; Bella A; Filia A; Gabutti G; Guido M; De Donno A; Ciofi degli Atti ML
    Ann Ig; 2007; 19(2):93-102. PubMed ID: 17547214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fetal risk associated with rubella vaccination during pregnancy.
    Badilla X; Morice A; Avila-Aguero ML; Saenz E; Cerda I; Reef S; Castillo-Solórzano C
    Pediatr Infect Dis J; 2007 Sep; 26(9):830-5. PubMed ID: 17721380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of congenital rubella and congenital varicella in Europe.
    Pandolfi E; Chiaradia G; Moncada M; Rava L; Tozzi AE
    Euro Surveill; 2009 Mar; 14(9):16-20. PubMed ID: 19317971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Tookey P; Morgan-Capner P; Hesketh L; Brown D; Waight P; Vurdien J; Jones G; Peckham C
    Commun Dis Rep CDR Rev; 1994 Nov; 4(12):R146-52. PubMed ID: 7529090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benefit-cost analysis of rubella vaccination policy.
    Schoenbaum SC; Hyde JN Jr Bartoshesky L; Crampton K
    N Engl J Med; 1976 Feb; 294(6):306-10. PubMed ID: 813141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Congenital rubella syndrome: continuing challenge of a preventable infection.
    Rhodes AJ
    Can Med Assoc J; 1977 Mar; 116(5):463-6. PubMed ID: 837306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.